Clinical Trial Update: Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the use of human albumin, hydroxyethyl starch, and lactated Ringer's solution during cardiac surgery has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Valvular Heart Disease

Drugs mentioned

• Human Albumin
• Hydroxyethyl starch (hydroxyethyl starch)
• Lactated Ringer's solution (Ringer's lactate solution)

Snippet

Sponsor: Medical University of Vienna | Conditions: Valvular Heart Disease, Coronary Artery Disease | Phase 4 | Status: COMPLETED